Spain: Boqapi ba Biotech - EIB e fana ka li-euro tse limilione tse 20 tsa lichelete ho Sanifit ho nts'etsapele liphekolo tsa calcification ea methapo.
- Banka ea EU e tla ts'ehetsa Sanifit e thehiloeng ho Palma mosebetsing oa eona oa ho nts'etsapele litharollo tsa morao-rao lipatlisisong tsa biomedical.
- Ts'ebetso ea mekoloto ea khoebo e tšehetsoa ke Leano la Investment bakeng sa Europe.
European Investment Bank (EIB) e ikemiselitse ho ts'ehetsa nts'etsopele ea liphekolo tse ncha tsa vascular calcification, e leng sebaka se nang le tlhoko e kholo e sa fihlelleheng moo ho se nang liphekolo tse lumelletsoeng. Ho finyella sena, the EU banka e tla fana ka kalimo ea li-euro tse limilione tse 20 ho k'hamphani ea Spain ea biopharmaceutical Sanifit, e ntseng e nts'etsapele liphekolo tse ncha matšoao a mabeli a mafu a amanang le calcification.
EIB e nts'etsapele lichelete tsa morero ona oa lipatlisiso, nts'etsopele le boqapi (RDI) ka ts'ebetso ea mekoloto ea khoebo le Moralo oa Matsete bakeng sa Europe tšehetso, sesebelisoa sa lichelete se sebelisoang ke banka ea EU ho thusa lik'hamphani tse etellang pele makaleng a macha. Ho tloha ha e thakholoa ke EIB tlas'a Morero oa Juncker ka 2016, mohato ona o fane ka chelete e fetang li-euro tse limilione tse likete tse peli bakeng sa lichelete bakeng sa merero libakeng tse kang liroboto, bohlale ba maiketsetso le biomedicine.
EIB e tla fana ka Sanifit ka lichelete tsa nako e telele ho tsamaisa nts'etsopele ea liphekolo bakeng sa mathata a ntseng a tsoela pele a vascular calcification. Khampani, e thehiloeng e le setsi sa ho tsoa Univesithing ea Lihlekehleke tsa Balearic, e hlahisitse SNF472, inhibitor e khethollang le e matla ea hydroxyapatite (HAP) crystallization, tsela ea ho qetela e tloaelehileng e lebisang ho vascular calcification.
Hona joale SNF472 e ntse e batlisisoa phuputsong ea Phase 3 bakeng sa phekolo ea calciphylaxis, lefu le kotsi le sa tloaelehang moo methapo e nyenyane ea mali letlalong le lisele tse mafura e koetsoeng ka lebaka la ho bala ho matla, ho lebisang lefung la hoo e ka bang 55% ea bakuli nakong ea selemo sa pele. ea ho hlahlojoa. Teko ea Mokhahlelo oa 3 sesupong sa bobeli, lefu la peripheral arterial, e leng sesosa se ka sehloohong sa lefu le lefu ho bakuli ba lefu la liphio le qetellong, e tla qala ka 2021.
Motlatsi oa Mopresidente oa EIB Emma Navarro, ea ikarabellang bakeng sa ts'ebetso ea Banka ho Spain, e totobalitse "phello e ntle ea ts'ebetso ena ho matlafatsa tlholisano ea indasteri ea bongaka ea Europe, lekala le hlokang matsete a maholo le litharollo tsa lichelete tse lokiselitsoeng. Re thabetse ho thusa k'hamphani e etelletseng pele ea Spain ho nts'etsapele liphekolo tse ncha tsa vascular calcification tse tla ba le melemo e hlakileng bakeng sa bophelo bo botle ba batho. Tumellano ena e toboketsa boitlamo ba EIB ba ho tshehetsa popontshwa ya Yuropa, eo ha jwale e leng bohlokwa ho feta leha e le neng pele bakeng sa ho kgothalletsa tsosoloso ya moruo le tlhahiso ya mesebetsi."
Ngaka Joan Perelló, Ofisiri e ka Sehloohong ea Phethahatso ea Sanifit, a re: “Tšehetso ea EIB e emela tšehetso e kholo ea thekenoloji ea rona le bokhoni ba eona ba ho thusa bakuli ba nang le maemo a fokolang a amanang le tsoelo-pele ea vascular calcification. Ena ke nako e monate haholo bakeng sa Sanifit ha re ntse re tsoela pele ka SNF472 ka tleliniki, 'me matsete ana a eketsehileng e tla ba a bohlokoa ha re ntse re bokella lintlha tsa morao-rao tse hlokahalang bakeng sa tumello, le ho fana ka mekhoa ea phekolo ho bakuli ba hlokang. "
Sanifit ke k'hamphani ea kliniki ea biopharmaceutical e tsepamisitseng maikutlo ho tsa kalafo bakeng sa mathata a vascular calcification. Khamphani e tsoa ho Univesithi ea Lihlekehleke tsa Balearic mme e na le liofisi ho Spain le US Thepa e etellang pele ea k'hamphani, SNF472, e atlehile ho phethela Mokhahlelo oa 2 bopaki ba boithuto ba mohopolo ho calciphylaxis mme e bonts'itse phokotso e kholo ea tsoelo-pele ea "coronary calcification" thutong ea Phase 2b har'a bakuli ba hemodialysis. Boithuto ba bohlokoa ba Phase 3 ho calciphylaxis bo ntse bo tsoela pele 'me teko ea Phase 3 ho Peripheral Arterial Disease in End-Stage Kidney Disease bakuli e tla qala ka 2021. Sanifit e hlahisitse chelete e ka bang $130M, ho kenyelletsa le 2019 Series D round ea $61.8M (€55.2) M) bohareng ba 2019. Ho fumana lintlha tse ling ka kopo etela www.sanifit.com
